Australia markets closed

Viridian Therapeutics, Inc. (1S1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
12.00+0.50 (+4.35%)
At close: 08:06AM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6665
Avg. Estimate-1.32-1.16-6.49-2.65
Low estimate-2.29-2.23-9.53-4.68
High estimate-0.26-0.32-2.82-1.38
Year ago EPS-1.5-5.31-11.48-6.49
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4455
Avg. Estimate570k650k3.49M1.97M
Low estimateN/AN/A2.5MN/A
High estimate1.27M1.31M5.12M5.64M
Year ago salesN/A54k1.05M3.49M
Sales growth (year/est)N/A1,103.70%232.40%-43.60%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-1.99-0.61-0.76-1.52
Actual EPS-1.5-5.31-2.91-2.21
Difference0.49-4.7-2.15-0.69
Surprise %24.60%-770.50%-282.90%-45.40%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-1.32-1.16-6.49-2.65
7 days ago-1.32-1.16-6.49-2.65
30 days ago-1.32-1.16-6.49-2.65
60 days ago-1.09-0.95-5.16-1.88
90 days ago-1.09-0.95-5.16-1.88
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates1S1.FIndustrySector(s)S&P 500
Current qtr.12.00%N/AN/AN/A
Next qtr.78.20%N/AN/AN/A
Current year43.50%N/AN/AN/A
Next year59.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A